A cuproptosis-related signature predicts prognosis and indicates cross-talk with immunocyte in ovarian cancer.
BiKang YangJuan YangKeqiang ZhangPublished in: Discover oncology (2024)
This study constructed a new cuproptosis-related gene signature that has a good prognostic capacity in assessing the outcome of OC patients. This study enhances our understanding of cuproptosis associated with ovarian cancer aggressiveness, cross-talk with immunocytes, and serves as a novel chemotherapy strategy.